Please login to the form below
Merck’s Bavencio joins first-line kidney cancer face-off
PD-L1 and TKI combination could challenge standard of care
Encouraging data for GenSight’s blinding retinal disease gene therapy
Better results after April's setback
AZ and Clovis PARP inhibitors show their mettle at ESMO
Lynparza and Rubraca both on track to extend cancer patient reach
AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery
Collaborates with Medicines Discovery Catapult on AMI-MS
Dynavax is ‘deal-ready’ after solid ESMO data; analyst
Contrasting results for two novel immunotherapies
UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
Big biopharma investment good news for gene sequencing company
Shire’s angioedema drug Takhzyro recommended in Europe
Analysts expect the drug to make around $1.8bn in peak sales
McCann Health London launch Urban Eye Test
Initiative aims to encourage the public to check their vision
Keytruda hits survival targets in first-line kidney cancer
New data presented at ESMO congress
The shifting healthcare landscape
-
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
The new basics Innovative products and creative marketing won’t help if our industry fails to address the new basics
-
Novartis buys cancer specialist Endocyte for $2.1bnAcquisition includes 'universal' CAR-T platform
-
Gilead and Aelix join forces to pursue HIV ‘cure’The HTI vaccine could replace antiretroviral therapy if it reaches market
-
Hancock's 'Tech Revolution' for NHS to be limited by budgetsVision for a tech-driven NHS unveiled, but is there money to fund it?
-
Roche preps new Kadcyla filings after phase 3 trial winSays the drug significantly reduced IDFS in women with residual disease
-
Ocrevus surge keeps Roche smiling in Q3MS drug is performing well, but immuno-oncology contender is in the doldrums
-
First Humira biosimilars reach EU marketWorld's biggest selling medicine to lose billions in sales
-
AZ says UK investments on hold until there is Brexit ‘clarity’Tomorrow's EU summit could be make-or-break for Brexit deal
Latest appointments
-
New starters join Four Communications, Emotive and McCann Health The latest movers in healthcare communications
-
Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expandsThe latest healthcare comms movers
-
imc, ROAD, Executive Insight and Life Healthcare adds to teamsThe latest med comms movers
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
-
Ashfield, Health Unlimited and Ashley Communications add to their teamsThe latest med comms movers
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Account Director
-
Negotiable
- Director Healthcare PR Communications
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Scientific Team Lead
-
Competitive Salary
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Experienced Editor, London, Medical Communications
-
Competitive package
-
Associate Medical Director
-
Salary TBC
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Account Director – Global Healthcare PR
-
Salary TBC
-
Associate Medical Director
-
Highly Competitive
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Account Manager, Healthcare Advertising
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Senior Systematic Review Analyst - Oxford
-
Negotiable
Subscribe to our email news alerts
- How pharma should navigate Artificial Intelligence (AI)
- Merck’s Bavencio joins first-line kidney cancer face-off
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Lonely planet: why there is dwindling value in pharma travelling alone
- AZ and Clovis PARP inhibitors show their mettle at ESMO
- AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery
PMHub
Atlantis Healthcare
Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe's leading hub for life sciences innovation...
Quick links
Infographics
